15-44626488-A-C
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_025137.4(SPG11):c.2087T>G(p.Ile696Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I696F) has been classified as Uncertain significance.
Frequency
Consequence
NM_025137.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 11Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
 - amyotrophic lateral sclerosis type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
 - Charcot-Marie-Tooth disease axonal type 2XInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
 - juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SPG11 | NM_025137.4  | c.2087T>G | p.Ile696Ser | missense_variant | Exon 11 of 40 | ENST00000261866.12 | NP_079413.3 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000394  AC: 6AN: 152220Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000120  AC: 3AN: 250862 AF XY:  0.00000738   show subpopulations 
GnomAD4 exome  AF:  0.00000342  AC: 5AN: 1461596Hom.:  0  Cov.: 31 AF XY:  0.00000138  AC XY: 1AN XY: 727086 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000394  AC: 6AN: 152220Hom.:  0  Cov.: 32 AF XY:  0.0000403  AC XY: 3AN XY: 74366 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.2087T>G (p.I696S) alteration is located in exon 11 (coding exon 11) of the SPG11 gene. This alteration results from a T to G substitution at nucleotide position 2087, causing the isoleucine (I) at amino acid position 696 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary spastic paraplegia 11    Uncertain:1 
This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 696 of the SPG11 protein (p.Ile696Ser). This variant is present in population databases (rs150746549, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SPG11-related conditions. ClinVar contains an entry for this variant (Variation ID: 466512). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at